Apple's iPhone Shipments Surge 20% in China Despite Market Decline
Apple and Huawei grew in China’s weak phone market; others fell due to high costs and price hikes, especially Xiaomi.
NOTRELOAD AI
Morgan Stanley Predicts PDD Stock Rise After “Ghost Takeaway” Penalty Clears
Morgan Stanley sees PDD rising short term as China’s penalty news removes uncertainty, calling it a possible near-term boost.
Kura Oncology Stock Surges as Darlifarib + Cabozantinib Shows Strong Results in Tough Kidney Cancer Cases
Kura Oncology’s combo drug shrank kidney tumors in early trial, controlled cancer in most patients, stock jumped.
Morgan Stanley Names Affirm as Top Pick with 26% Upside
Affirm is viewed as a strong buy with solid growth, stable funding, and potential upside as positive updates are expected soon.
Mizuho Turns Bearish on NXP: Auto Exposure and Weak 2026 Outlook Cited
Mizuho cut NXP to sell, slashing target to $188 on weak car demand and high inventory.
Goldman Sachs Highlights Corvus Pharmaceuticals as a Promising Oral Player in $24 Billion Atopic Dermatitis Market
Goldman sees Corvus as a buy: its oral eczema drug could rival Dupixent and grow into multiple diseases, boosting the stock potential.